SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Skinvisible, Inc. – ‘10-Q’ for 9/30/23 – ‘EX-31.2’

On:  Tuesday, 11/14/23, at 9:14pm ET   ·   As of:  11/15/23   ·   For:  9/30/23   ·   Accession #:  1663577-23-536   ·   File #:  0-25911

Previous ‘10-Q’:  ‘10-Q’ on 8/14/23 for 6/30/23   ·   Latest ‘10-Q’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/15/23  Skinvisible, Inc.                 10-Q        9/30/23   41:2.3M                                   Edgar Einsteins, Inc./FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    536K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     17K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     17K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     14K 
10: R1          Cover                                               HTML     62K 
11: R2          Consolidated Balance Sheets (Unaudited)             HTML    115K 
12: R3          Consolidated Statements of Operations (Unaudited)   HTML     90K 
13: R4          Consolidated Statements of Stockholders' Deficit    HTML     46K 
                (Unaudited)                                                      
14: R5          Consolidated Statements of Cash Flows (Unaudited)   HTML     87K 
15: R6          1. Description of Business and History              HTML     18K 
16: R7          2. Basis of Presentation and Going Concern          HTML     20K 
17: R8          3. Summary of Significant Policies                  HTML     35K 
18: R9          4. Intangible and Other Assets                      HTML     18K 
19: R10         5. Related Party Transactions                       HTML     39K 
20: R11         6. Notes Payable                                    HTML     21K 
21: R12         7. Convertible Notes Payable                        HTML     36K 
22: R13         8. Commitments and Contingencies                    HTML     22K 
23: R14         9. Stockholders? Deficit                            HTML     22K 
24: R15         10. Subsequent Events                               HTML     16K 
25: R16         1. Description of Business and History (Policies)   HTML     19K 
26: R17         2. Basis of Presentation and Going Concern          HTML     22K 
                (Policies)                                                       
27: R18         3. Summary of Significant Policies (Policies)       HTML     57K 
28: R19         5. Related Party Transactions (Tables)              HTML     35K 
29: R20         7. Convertible Notes Payable (Tables)               HTML     35K 
30: R21         3. Summary of Significant Policies (Details         HTML     15K 
                Narrative)                                                       
31: R22         4. Intangible and Other Assets (Details Narrative)  HTML     20K 
32: R23         5. RELATED PARTY TRANSACTIONS - Schedule of         HTML     60K 
                Convertible Notes Payable Related Party (Details)                
33: R24         7. CONVERTIBLE NOTES PAYABLE - Schedule of          HTML     69K 
                Convertible Notes Payable (Details)                              
34: R25         6. Notes Payable (Details Narrative)                HTML     24K 
35: R26         8. Commitments and Contingencies (Details           HTML     26K 
                Narrative)                                                       
36: R27         9. Stockholders? Deficit (Details Narrative)        HTML     23K 
39: XML         IDEA XML File -- Filing Summary                      XML     65K 
37: XML         XBRL Instance -- skvi10q093023_htm                   XML    438K 
38: EXCEL       IDEA Workbook of Financial Report Info              XLSX     59K 
 3: EX-101.CAL  XBRL Calculations -- skvi-20230930_cal               XML     87K 
 4: EX-101.DEF  XBRL Definitions -- skvi-20230930_def                XML    119K 
 5: EX-101.LAB  XBRL Labels -- skvi-20230930_lab                     XML    384K 
 6: EX-101.PRE  XBRL Presentations -- skvi-20230930_pre              XML    301K 
 2: EX-101.SCH  XBRL Schema -- skvi-20230930                         XSD     60K 
40: JSON        XBRL Instance as JSON Data -- MetaLinks              208±   294K 
41: ZIP         XBRL Zipped Folder -- 0001663577-23-000536-xbrl      Zip    128K 


‘EX-31.2’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



CERTIFICATIONS

 

I, Terry Howlett, certify that;

 

1.   I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 of Skinvisible, Inc. (the “registrant”);

 

2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.   The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.   The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2023

 

/s/ Terry Howlett

By: Terry Howlett

Title: Chief Financial Officer


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed as of:11/15/23NT 10-Q
Filed on:11/14/23NT 10-Q
For Period end:9/30/23NT 10-Q
 List all Filings 
Top
Filing Submission 0001663577-23-000536   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 3:12:37.1pm ET